Table 1

Allele and genotype frequencies at the APOE locus among demented and non-demented CFAS subjects, overall

Farrer et al6
ControlsCasesCrude OR (95% CI)Adjusted* OR (95% CI)Rubinsztein and Easton7Population basedClinic/necropsy
*Adjusted for age, sex, and years of full time education.
†Pooled estimate OR (95% CI) for Alzheimer’s disease.
‡Pooled estimate OR (95% CI) for Alzheimer’s disease, adjusted for age and study.
Allele
    ε37222461.01.01.0
    ε285260.9 (0.6 to 1.4)0.7 (0.4 to 1.2)0.7 (0.6 to 0.8)
    ε4125521.2 (0.9 to 1.7)1.5 (1.1 to 2.2)3.4 (3.0 to 3.6)
Genotype
    ε3/ε3277971.01.01.01.01.0
    ε2/ε2432.1 (0.5 to 9.7)0.5 (0.1 to 5.2)0.9 (0.4 to 2.0)0.9 (0.3 to 2.8)0.6 (0.2 to 2.0)
    ε2/ε367150.6 (0.3 to 1.2)0.5 (0.2 to 1.2)0.6 (0.5 to 0.7)0.6 (0.5 to 0.9)0.6 (0.5 to 0.8)
    ε2/ε41051.4 (0.5 to 4.3)1.7 (0.4 to 6.6)1.9 (1.3 to 2.8)1.2 (0.8 to 2.0)2.6 (1.6 to 4.0)
    ε3/ε4101371.0 (0.7 to 1.6)1.1 (0.6 to 1.9)3.4 (3.0 to 3.9)2.7 (2.2 to 3.2)3.2 (2.8 to 3.8)
    ε4/ε4752.0 (0.6 to 6.6)3.8 (1.0 to 14.0)13.3 (9.9 to 17.9)12.5 (8.8 to 17.7)14.9 (10.8 to 20.6)